DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ipratropium and Albuterol (Albuterol Sulfate / Ipratropium Bromide Inhalation) - Published Studies

 
 



Published Studies Related to Ipratropium and Albuterol (Albuterol / Ipratropium Inhalation)

Well-designed clinical trials related to Ipratropium and Albuterol (Albuterol / Ipratropium Inhalation)

Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children. [2011.04]

Levalbuterol versuss levalbuterol plus ipratropium in the treatment of severe acute asthma. [2010.12]

Functional response to inhaled salbutamol and/or ipratropium bromide in Ascaris suum-sensitised cats with allergen-induced bronchospasms. [2010.10]

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. [2010.08]

Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. [2009.12]

Beneficial effects of warmed humidified oxygen combined with nebulized albuterol and ipratropium in pediatric patients with acute exacerbation of asthma in winter months. [2009.11]

[Efficacy of two methods of administration of salbutamol-ipratropium bromide in asthma crises] [2009.09]

High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial. [2009.08]

Comparative efficacy of combined nebulized salbutamol with ipratropium bromide and nebulized adrenaline to treat children with acute bronchiolitis. [2009.07]

A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. [2008.08]

Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. [2008.08]

Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. [2008.07]

[Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study.] [2008.03]

Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial. [2008]

Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction. [2007.09]

Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. [2007.06]

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. [2007.06]

Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials. [2007.03.06]

Well-designed clinical trials possibly related to Ipratropium and Albuterol (Albuterol / Ipratropium Inhalation)

Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study. [2014]

Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbation. [2014]

Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial. [2013]

The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to bronchodilators: a pilot study. [2012]

Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011.07]

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. [2011.01.11]

Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. [2010.12]

Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD. [2010.08.31]

Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD. [2010.07]

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. [2010.04.01]

Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD. [2010]

Transient expiratory flow interruptions (TEFI) increase expiratory flow in acute asthma exacerbation. [2009]

A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in acute severe asthma. [2008.12]

Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. [2008.08]

Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. [2008.04]

Bronchodilator responsiveness in patients with COPD. [2008.04]

Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. [2008.04]

Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD. [2008]

Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. [2007.05]

The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD. [2007.04]

Other research related to Ipratropium and Albuterol (Albuterol / Ipratropium Inhalation)

Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma. [2013]

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study. [2013]

Effects on aerosol performance of mixing of either budesonide or beclomethasone dipropionate with albuterol and ipratropium bromide. [2011.03]

Development and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol, budesonide, and ipratropium bromide in compounded nebulizer solutions. [2011.01]

Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution. [2010.05.01]

Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics. [2010.04]

Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease. [2010.03]

Economic analyses comparing tiotropium with ipratropium or salmeterol in UK patients with COPD. [2010.03]

Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. [2009.09.06]

The effects of racemic albuterol versus levalbuterol in very low birth weight infants. [2009.08]

Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD. [2009.06]

A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats. [2009.05]

Nebulized formoterol effect on bronchodilation and satisfaction in COPD patients compared to QID ipratropium/albuterol MDI *. [2009.03]

Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium. [2008.12]

Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. [2008.08]

Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibility. [2008.08]

Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study. [2008.06]

[Voiding difficulties in a child attributed to the use of ipratropium and salbutamol] [2007.12.08]

Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol. [2007.10]

Exploratory economic evaluation of patients with COPD on a combination product versus individual components (ipratropium bromide and albuterol). [2007.07]

Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. [2007]

Other possibly related research studies

Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research. [2008.12]

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. [2009.01]

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*. [2008.12]

Effect of educational and policy interventions on institutional utilization of wet nebulization respiratory drugs and portable inhalers. [2008.06]

Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. [2008.07]

An under-recognized complication of treatment of acute severe asthma. [2008.05]

Paediatric acute asthma management in Australia and New Zealand: practice patterns in the context of clinical practice guidelines. [2008.04]

[Inhaled therapy via nebulization: practical issues] [2007.07]

Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. [2007.06]

Aseptic femoral head necrosis in a patient receiving long term courses of inhaled and intranasal corticosteroids. [2007]

Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease. [2007.05]

Plethysmographic comparison of breathing pattern in heaves (recurrent airway obstruction) versus experimental bronchoconstriction or hyperpnea in horses. [2007.01]

Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease. [2007.03]

Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. [2007.01]

Utilization of bronchodilators in ventilated patients without obstructive airways disease. [2007.02]

Salmeterol/fluticasone treatment reduces circulating C-reactive protein level in patients with stable chronic obstructive pulmonary disease. [2010.07]

Electrostatic charge characteristics of jet nebulized aerosols. [2010.06]

Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. [2010.06]

Usefulness of inhaled magnesium sulfate in the coadjuvant management of severe asthma crisis in an emergency department. [2010.10]

Inhaled morphine for palliation of dyspnea in end-stage cystic fibrosis. [2010.05.01]

[Long-term trials assessing pharmacological treatments in COPD: lessons and limitations] [2010.02]

Management of COPD exacerbations. [2010.03.01]

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. [2009.10]

Inhaled tiotropium bromide and risk of stroke. [2009.11]

Acute severe asthma: new approaches to assessment and treatment. [2009]

Review article: management of acute severe and near-fatal asthma. [2009.08]

Effects of inhalational bronchodilator treatment during noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations. [2009.09]

Reversible airflow obstruction in lymphangioleiomyomatosis. [2009.12]

Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients. [2011.12]

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. [2010.12.31]

Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis. [2010.09.21]

A new method for examining the cost savings of reducing COPD exacerbations. [2010]

Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. [2010.07]

Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. [2010.11]

Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents. [2011.01]

Dry powder aerosols generated by standardized entrainment tubes from alternative sugar blends: 3. Trehalose dihydrate and D-mannitol carriers. [2010.08]

Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 mug/salmeterol 50 mug combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD. [2009]

Anticholinergic therapy for acute asthma in children. [2012]

A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction. [2012]

Randomized controlled trial of a breath-activated nebulizer in patients with exacerbation of COPD. [2012]

Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients. [2011]

Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017